Related Experiment Videos
Diamonds in the rough: protein crystals from a formulation perspective
1Department of Applied BioSciences, Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland.
Pharmaceutical Research
|January 5, 2002
Summary
Protein crystals offer a promising approach to formulation design for stabilizing protein therapeutics. This review explores their potential, methods, and challenges for developing crystalline protein drugs.
Area of Science:
- Pharmaceutical Science
- Biotechnology
- Drug Delivery
Background:
- Protein crystallization for drug formulation, though known since the 1920s (e.g., insulin crystals), remains less explored than other stabilization methods.
- Macromolecular crystallization presents a viable, yet underutilized, strategy for enhancing the stability of protein-based therapeutics.
Purpose of the Study:
- To review the potential of crystalline protein formulations.
- To introduce concepts and tools for developing protein crystals into drug products.
- To discuss formulation challenges, regulatory considerations, and current applications.
Main Methods:
- Literature review of macromolecular crystallization techniques.
- Analysis of advances in protein crystallization for formulation.
- Examination of case studies and regulatory landscapes.
Main Results:
- Protein crystals offer significant potential for stabilizing protein drug candidates.
- New advances provide tools for developing crystalline protein formulations.
- Current applications demonstrate the feasibility of protein crystal formulations.
Conclusions:
- Macromolecular crystallization is a valuable, albeit underexplored, strategy in pharmaceutical formulation.
- Further research and development are warranted to fully leverage protein crystals for drug delivery.
- Addressing formulation and regulatory challenges will facilitate clinical translation.